Prevalence of rheumatoid factor and parameters associated with rheumatoid factor positivity in Korean health screening subjects and subjects with hepatitis B surface antigen

Modern Rheumatology

Volumn 22, Issue 6, 2012, Pages 885-891

  Shim, Choong Nam ^a   Hwang, Ji Won ^b   Lee, Jaejoon ^b   Koh, Eun Mi ^b   Cha, Hoon Suk ^b   Ahn, Joong Kyong ^a  

^a School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Health screening; Hepatitis B infection; Korean; Rheumatoid factor

Indexed keywords

C REACTIVE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGING; ARTHRALGIA; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SOUTH KOREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; SEROEPIDEMIOLOGIC STUDIES;

EID: 84870361744     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0603-3     Document Type: Article

References (27)

1. Soltys AI, Axford JS, Sutton BJ. Rheumatoid factors: where are we now? Ann Rheum Dis. 1997;56:285-6.
2. Halldorsdottir HD, Jonsson T, Thorsteinsson J, Valdimarsson H. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann Rheum Dis. 2000;59:149-51.
3. Goodyear CS, Tighe H, McInnes LB. Rheumatoid factors and other autoantibodies in rheumatoid arthritis. In: Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, editors. Kelly's textbook of rheumatology. 8th ed. Philadelphia: Saunders Elsevier; 2009. p. 755-65.
4. Litwin SD, Singer JM. Studies of the incidence and significance of anti-gamma globulin factors in the aging. Arthritis Rheum. 1965;8:538-50.
5. Pai S, Pai L, Birkenfeldt R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol. 1998;27:252-6.
6. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol. 2009;15(Suppl 6): S13-24.
7. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337: 1733-45.
8. Watanabe K, Ohkubo Y, Funahashi Y, Nishimaki T, Moritoh T, Kasukawa R, et al. An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers. Clin Rheumatol. 1991;10:31-7.
9. Yeh HM, Chiang W, Chen SF, Dai SM, Shin NH, Wu CS, et al. Rheumatoid factor in hepatitis B virus surface antigen positive patients. Gaoxiong Yi Xue Ke Xue Za Zhi. 1994;10:239-43.
10. Lee SI, Yoo WH, Yun HJ, Kim DS, Lee HS, Choi SI, et al. Absence of antibody to cyclic citrullinated peptide in sera of nonarthritic patients with chronic hepatitis B virus infection. Clin Rheumatol. 2007;26:1079-82.
11. Cacoub P, Saadoun D, Bourliere M, Khiri H, Martineau A, Benhamou Y, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol. 2005;43:764-70.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112: 2735-52.
13. Uhm WS, Cho JK, Chung DR, Choi SW, Lee M-S, Yoo B. The prevalence of serum rheumatoid factor in health screening subjects and its relation to hepatitis virus infection. Korean J Intern Med. 1996;50:551-6 (Korean).
14. Hooper B, Whittingham S, Mathews JD, Mackay IR, Curnow DH. Autoimmunity in a rural community. Clin Exp Immunol. 1972;12:79-87.
15. Ailus K, Melamies L, Tuomi T, Palosuo T, Aho K. Measuring rheumatoid factor in nonrheumatoid subjects: immunoturbidimetric assay, latex slide test, and enzyme-linked immunosorbent assay compared. Clin Chem. 1991;37:1766-9.
16. Tuomi T, Heliovaara M, Palosuo T, Aho K. Smoking, lung function, and rheumatoid factors. Ann Rheum Dis. 1990;49: 753-6.
17. Spector TD, Hart DJ, Powell RJ. Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline. Ann Rheum Dis. 1993;52:254-7.
18. Newkirk MM. Rheumatoid factors: what do they tell us? J Rheumatol. 2002;29:2034-40.
19. Williams RC Jr. Rheumatoid factors: historical perspective, origins and possible role in disease. J Rheumatol Suppl. 1992;32: 42-5.
20. Lisse Jr. Does rheumatoid factor always mean arthritis? Postgrad Med. 1993;94:133-4, 9.
21. Wolfe F, Cathey MA, Roberts FK. The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients. Arthritis Rheum. 1991;34:951-60.
22. Mathews JD, Whittingham S, Hooper BM, Mackay IR, Stenhouse NS. Association of autoantibodies with smoking, cardiovascular morbidity, and death in the Busselton population. Lancet. 1973;2: 754-8.
23. Bhatia SS, Majka DS, Kittelson JM, Parrish LA, Ferucci ED, Deane KD, et al. Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis. Ann Rheum Dis. 2007;66:267-9.
24. Jonsson T, Thorsteinsson J, Valdimarsson H. Does smoking stimulate rheumatoid factor production in non-rheumatic individuals? APMIS. 1998;106:970-4.
25. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50:3085-92.
26. Orge E, Cefle A, Yazici A, Gurel-Polat N, Hulagu S. The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatol Int. 2010;30:485-8.
27. Koga T, Migita K, Miyashita T, Maeda Y, Nakamura M, Abiru S, et al. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases. Clin Exp Rheumatol. 2008;26:121-4.